Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Needham Analyst Reiterates Buy Rating on ChargePoint Holdings with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Technology Data analytics stock Trading (1)
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Needham analyst Chris Pierce has reiterated his Buy rating on ChargePoint Holdings (NYSE: CHPT) on March 6, 2024. However, he has revised the price target downward from $4 to $3. This change reflects Pierce’s assessment of the company’s performance in relation to current market conditions. Pierce remains optimistic about ChargePoint Holdings’ potential for growth despite the price target adjustment.

ChargePoint Holdings Inc. (CHPT) Stock Declines on March 6, 2024: What Investors Need to Know

On March 6, 2024, ChargePoint Holdings Inc. (CHPT) experienced a decline in its stock performance. According to data from CNN Money, CHPT is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be facing some downward pressure in the market.

The price of CHPT shares dropped by $0.07 since the market last closed, representing a 3.38% decrease. The stock closed at $2.00 on the previous trading day. Furthermore, in pre-market trading on March 6, the stock dropped an additional $0.10.

This recent decline in CHPT’s stock price may be concerning for investors, as it suggests that the stock is currently experiencing negative momentum. Investors may be cautious about the company’s future prospects and performance in the market.

ChargePoint Holdings Inc. (CHPT) Financial Performance Analysis: Revenue Surges, Net Loss Narrows

On March 6, 2024, ChargePoint Holdings Inc. (CHPT) saw a mixed performance in terms of its financials. According to data from CNN Money, the total revenue for the company stood at $468.09 million over the past year, showing an impressive 94.23% increase compared to the previous year. However, the total revenue for the third quarter of the fiscal year was reported at $110.28 million, reflecting a significant 26.72% decrease from the previous quarter.

In terms of net income, ChargePoint reported a net loss of $345.11 million over the past year, marking a substantial 160.97% decrease from the previous year. The net loss for the third quarter was reported at $158.22 million, showing a 26.32% decrease from the previous quarter.

Earnings per share (EPS) for ChargePoint stood at -$1.02 over the past year, which represents a 31.72% increase compared to the previous year. However, the EPS for the third quarter was reported at -$0.42, indicating a 19.49% decrease from the previous quarter.

Tags: CHPT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Retailers Trading online

Abercrombie Fitch Forecasts Strong Sales Growth and Improved Margins for Q1 2024

Retail Market Capitalization

Analyst Maintains Underweight Rating on Nordstrom with Increased Price Target

Healthcare-and-IT

Analyst Reiterates Bullish Outlook on Praxis Precision Medicine

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com